Cargando…
CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
Following cancer treatment, patients often report behavioral and cognitive changes. Novel cancer immunotherapeutics have the potential to produce sustained cancer survivorship, meaning patients will live longer with the side effects of treatment. Given the role of inflammatory pathways in mediating...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161123/ https://www.ncbi.nlm.nih.gov/pubmed/29338610 http://dx.doi.org/10.2217/imt-2017-0056 |